Marketplace Donate Now Become a Member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

Feb 23, 2017 7:00 AM - Feb 24, 2017 5:00 PM

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advertising and Promotion Regulatory Affairs Conference

Back to Agenda

Session 1: FDA: Focus on Enforcement

Session Chair(s)

Wayne Pines

Wayne Pines

President, Health Care, United States

This session will focus on FDA’s new initiatives and recent enforcement actions. Representatives from four FDA centers will dive deeper into specific recent enforcement actions, which will offer insights into the agency’s thought process on enforcement actions. The Office of Prescription Drug Promotion Director, Tom Abrams, will share an update on recent policy initiatives, and how they have evolved at the agency based on the November hearing, as well as other initiatives emerging from FDA in the new year.

Speaker(s)

Thomas W. Abrams, MBA, RPH

Thomas W. Abrams, MBA, RPH

Retired, Director, Office of Prescription Drug Promotion, OMP, CDER, Former FDA, United States

Speaker

Lisa Stockbridge, PHD

Lisa Stockbridge, PHD

Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States

Speaker

Representative Invited

Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States

Speaker

Representative Invited

Supervisor VMO, FDA/CMV, United States

Speaker

Thomas J. Moskal, DVM

Thomas J. Moskal, DVM

Veterinary Medical Officer, FDA/CVM, United States

Speaker

Have an account?